Tanaka A, Yamauchi A, Ohsawa H, Koyanagi T, Sato T, Sakata J, Maekawa K, Watanabe N, Obama T, Sato H
Department of Thoracic Surgery, Sapporo City General Hospital, Japan.
Kyobu Geka. 1999 May;52(5):347-54.
Six cases of thymic carcinoma (mean age 48.5 years old, one male and 5 females) were treated in our hospital from September 1990 to September 1998. The histological subtypes of thymic carcinoma were squamous cell in 4, undifferentiated in one, and small cell in one. All cases underwent midsternal thoracotomy, 4 had total resection of the tumor and 2 had exploratory thoracotomy due to tumor invasion of the aorta and the main pulmonary artery. Within 2 years after operation, 2 cases without radiation therapy were died of the carcinoma and one case was died of asthma. However, two cases of squamous cell carcinoma have been alive and disease free for 3 and 5 years since the operation followed by mediastinal irradiation. We think that radiation therapy is very effective to control the disease because one of them underwent only exploratory operation prior to irradiation. Another one case who survives 5 years after total resection of the tumor following irradiation revealed swelling of numerous mediastinal lymph nodes, pathologically consisted of non-caseating epithelioid cell granulomas without metastasis of carcinoma, at the time of operation. These lymph nodes were diagnosed as "sarcoid-like reaction" because there was no clinical evidence of generalized sarcoidosis. The "sarcoid-like reaction" may contribute to the 5-year survival of the patient because it is thought to be a local immune response against the cancer cells. A remaining patient, alive 6 months after total resection of the thymic small cell carcinoma following irradiation, received preoperatively three cycles of the intra-arterial administration using CBDCA via bilateral internal mammary arteries. This induction chemotherapy had no response of the tumor size, but it was considered to have a possibility of reducing the size of thymic carcinoma by the use of other agents (CDDP, VDS etc.) because the tumor was fed mainly by the highly developed internal mammary arteries.
1990年9月至1998年9月,我院共收治6例胸腺癌患者(平均年龄48.5岁,男1例,女5例)。胸腺癌的组织学亚型中,鳞状细胞癌4例,未分化癌1例,小细胞癌1例。所有病例均行胸骨正中切开术,4例肿瘤完全切除,2例因肿瘤侵犯主动脉和主肺动脉而行开胸探查术。术后2年内,2例未接受放疗的患者死于癌症,1例死于哮喘。然而,2例鳞状细胞癌患者术后接受纵隔照射,分别存活3年和5年,无疾病复发。我们认为放疗对控制疾病非常有效,因为其中1例仅在放疗前接受了探查手术。另一例患者在放疗后肿瘤完全切除后存活5年,手术时发现纵隔内多个淋巴结肿大,病理检查为非干酪样上皮样细胞肉芽肿,无癌转移。这些淋巴结被诊断为“类肉瘤样反应”,因为没有全身性结节病的临床证据。“类肉瘤样反应”可能有助于患者的5年生存,因为它被认为是对癌细胞的局部免疫反应。剩下的1例患者在胸腺小细胞癌完全切除并放疗后存活6个月,术前通过双侧乳内动脉接受了3个周期的卡铂动脉内给药。这种诱导化疗对肿瘤大小无反应,但考虑到肿瘤主要由高度发达的乳内动脉供血,使用其他药物(顺铂、长春地辛等)有可能缩小胸腺癌的大小。